Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a tim…
Medical - Devices
US, Acton [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Insulet Corporation's gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | -0.8300 | -0.330 | 247 | 193 | -44 | -210 | -29 | -97 | -29 | -53 | 119 | 82 |
| 2015 | -0.9300 | -1.071 | 288 | 315 | -51 | -60 | -12 | -37 | -12 | -50 | 127 | 136 |
| 2016 | -1.2900 | -0.374 | 263 | 363 | -73 | -33 | -32 | 1 | -48 | -11 | 138 | 202 |
| 2017 | -0.5000 | -0.440 | 366 | 458 | -28 | -23 | -9 | 10 | -10 | -5 | 166 | 198 |
| 2018 | -0.4600 | -0.035 | 463 | 561 | -26 | -2 | -7 | 44 | -7 | 17 | 210 | 240 |
| 2019 | 0.0559 | 0.223 | 563 | 728 | 3 | 29 | 27 | 153 | 27 | 91 | 254 | 622 |
| 2020 | 0.1900 | 0.325 | 738 | 891 | 11 | 23 | 50 | 71 | 50 | 27 | 300 | 381 |
| 2021 | 0.1100 | 0.129 | 904 | 1,091 | 6 | 4 | 54 | 141 | 51 | 130 | 384 | 546 |
| 2022 | 0.2500 | 0.416 | 1,098 | 1,268 | 16 | -70 | 124 | 114 | 126 | 12 | 466 | 1,028 |
| 2023 | 0.0663 | 1.990 | 1,305 | 1,648 | 4 | 395 | 36 | 126 | 37 | 13 | 587 | 1,131 |
| 2024 | 2.9600 | 3.671 | 1,697 | 2,016 | 206 | 270 | 220 | 160 | 220 | 63 | 734 | 862 |
| 2025 | - | 3.867 | - | 2,392 | - | 287 | - | 190 | - | 74 | - | 1,023 |
| 2026 | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F12X/td> | - | 2.F121/td> | - | 2.F121 | - | 2.F121 |
| 2027 | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F13X/td> | - | 1.F131/td> | - | 1.F131 | - | 1.F131 |
| 2028 | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F14X/td> | - | 0.F141/td> | - | 0.F141 | - | 0.F141 |